Indications
OTC - PURPOSE SECTION
For relief of yeast infections.
For relief of yeast infections.
Spray twice into each nostril three times daily.
15ml Candida parapsilosis 4X in a base of purified water, 0.135g sodium chloride, 0.015g potassium sorbate.
If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before using this product.
Keep this and all medications out of the reach of children. Protect from light and heat.
Do not use product if tamper evident strip is broken.
To report adverse events, contact BioResource at 707/664-9023 or bioresource2@prodigy.net
Distributed by:
BioResource Inc.
Cotati CA 94931
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54256-099-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c5a4-f424-e053-dadaa90a57ce | Candida Nasal Spray 4X |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54256-099-05 | Candida | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | 1 | |
| 54256-099-05 | Candida | 1 in 1 BOX | SPRAY | 1 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54256-099 | 54256-099-05 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Candida parapsilosis | 0KZ676D44N | ACTIB |
| Water | 059QF0KO0R | IACT |
| Sodium chloride | 451W47IQ8X | IACT |
| Potassium sorbate | 1VPU26JZZ4 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 52359708-5c43-441f-b496-16896351b85f | 872f851f-6f84-4263-9b7b-e0833a97f941 | 2016-09-02 | Warnings | 52359708-5c43-441f-b496-16896351b85f 872f851f-6f84-4263-9b7b-e0833a97f941 |
Adverse event summaries are temporarily unavailable. Other product information remains available.